Institute of Biomedical Research Corp.
MRES
Rank in Stocks
#31245
Institute of Biomedical Research Corp. (MRES) is a dedicated provider of... Institute of Biomedical Research Corp. (MRES) is a dedicated provider of comprehensive biomedical research and analytical services, operating both within Montenegro and across international markets. The company's core activities encompass fundamental scientific investigation and robust research and development initiatives for new biomedical products, advanced technologies, and innovative diagnostic methods, including experimental medical treatments. MRES also focuses on the creation of novel biomedical and food products. A significant part of its mandate involves regulatory oversight of industrial activities and their associated products, alongside scientific environmental monitoring. Furthermore, it delivers expert regulatory evaluation and certification services for a wide array of biomedical products. The institute also contributes to academic advancement through graduate research study programs in the biomedical and environmental fields. MRES manufactures and supplies a diverse range of healthcare devices. Its offerings include two-channel analog NMS units, various digital muscle stimulators, digital TENS devices, interferential therapy units, elite combination models, portable four-channel digital stimulators, and portable ultrasound equipment. The product portfolio also extends to photon red light devices for aesthetic applications, electric pain relief solutions, microcurrent electrical nerve stimulators, and high-volt pulsed stimulators. The company excels in the development and commercialization of specialized agents and products. This category features microbicidal agents, a variety of disinfectant solutions, and specialized medical supplies such as bandages tailored for severe burns. They also provide products for hard surface disinfection, microbicidal treatments for fabrics and textiles, insecticides (including those targeting bed bugs), microbicidal towels, and mouthwash. Key innovations include Purilair, an apparatus specifically designed for sterilizing compressed air within medical instruments, alongside colloidal silver and other electro-medical devices. A notable product is BioStim INF, which is engineered for reducing edema, alleviating pain, and delivering comprehensive therapeutic benefits. Beyond its product and research endeavors, MRES offers a broad spectrum of essential services. These include quality control, regulatory assistance, healthcare support, environmental analysis, building decontamination, and extensive environmental protection and management services. They are also a critical source for regulatory certifications of new biomedical products. Institute of Biomedical Research Corp. was established in 2010 and maintains its headquarters in Podgorica, Montenegro, with a representative office located in Montreal, Canada, facilitating its global operations.
Share Price
$0.0012
Last synced: 2026-11-09
Market Cap
$3.46M
Change (1 day)
0.00%
Change (1 year)
-85.00%
Country
ME
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Institute of Biomedical Research Corp. (MRES)
Category
Healthcare
Operating Margin for Institute of Biomedical Research Corp. (MRES)
Operating Margin as of November 2026 TTM: -505.76%
According to Institute of Biomedical Research Corp.'s latest financial reports, its current operating margin (TTM) is -505.76%. At the end of 2025 the company had an operating margin of -1,528.71%.
Operating Margin history for Institute of Biomedical Research Corp. from 2003 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -505.76% | -66.92% |
| 2025 | -1,528.71% | -61.64% |
| 2024 | -3,985.00% | 62.09% |
| 2023 | -2,458.48% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | 0.00% |
| 2010 | 0.00% | 0.00% |
| 2009 | 0.00% | 0.00% |
| 2008 | 0.00% | 0.00% |
| 2007 | 0.00% | 0.00% |
| 2006 | 0.00% | 0.00% |
| 2004 | 0.00% | 0.00% |
| 2003 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.08% |
US
|
|
| -149.01% | -99.71% |
US
|
|
| 25.57% | -100.05% |
AU
|
|
| 31.23% | -100.06% |
BE
|
|
| 29.35% | -100.06% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Institute of Biomedical Research Corp.'s operating margin
What is Institute of Biomedical Research Corp.'s operating margin?
Institute of Biomedical Research Corp.'s operating margin is -505.76%, as of Nov 2026.
What was Institute of Biomedical Research Corp.'s operating margin in 2025?
In 2025, Institute of Biomedical Research Corp.'s operating margin was -1,528.71%, compared with -3,985.00% in 2024.
How has Institute of Biomedical Research Corp.'s operating margin changed since 2021?
From 2021 to 2025, Institute of Biomedical Research Corp.'s operating margin was highest in 2022 (0.00%) and lowest in 2024 (-3,985.00%).
How does Institute of Biomedical Research Corp.'s operating margin compare with similar companies?
Institute of Biomedical Research Corp.'s operating margin (-505.76%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.